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Tight junctions are dynamic components of epithelial and
endothelial cells that regulate the paracellular transport of ions,
solutes, and immune cells. The assembly and permeability of
these junctions is dependent on the zonula occludens (ZO) pro-
teins, members of the membrane-associated guanylate kinase
homolog (MAGUK) protein family, which are characterized by a
core Src homology 3 (SH3)-GUKmodule that coordinates mul-
tiple protein-protein interactions. The structure of the ZO-1
SH3-GUK domain confirms that the interdependent folding of
the SH3 and GUK domains is a conserved feature of MAGUKs,
but differences in the orientation of the GUK domains in three
different MAGUKs reveal interdomain flexibility of the core
unit. Using pull-down assays, we show that an effector loop, the
U6 region in ZO-1, forms a novel intramolecular interaction
with the coremodule. This interaction is divalent cation-depen-
dent and overlaps with the binding site for the regulatory mole-
cule calmodulin on the GUK domain. These findings provide
insight into the previously observed ability of the U6 region to
regulateTJ assembly in vivo and the structural basis for the com-
plex protein interactions of the MAGUK family.
The assembly and functional organization of plasma mem-
brane domains, such as synapses and cell adhesions, depends
on the temporally and spatially regulated assembly ofmultipro-
tein complexes. In one common paradigm, the trafficking
and assembly of the transmembrane receptors and adhesion
molecules that form these complexes is organized by a series of
cytosolic scaffolding proteins. One of the most common and
ubiquitous families of scaffolding molecules is the membrane-
associated guanylate kinase homologs (MAGUKs).2 Founding
members of this family include the discs large tumor suppressor
inDrosophila, Lin2, which is required for RT kinase signaling in
Caenorhabditis and PSD-95 and its related synaptic scaffolding
proteins, which also control channel activity. This diverse fam-
ily of proteins is characterized by a core motif of protein-bind-
ing domains, including a PSD-95/DLG/ZO-1 (PDZ) domain, an
Src homology 3 (SH3) domain, and a region of homology to
guanylate kinase referred to as the GUK domain (Fig. 1A)
(reviewed in Ref. 1). Most also include additional PDZ domains
or other conserved protein-binding domains. These domains
are separated by unique regions (U regions), which can also
have protein-binding and regulatory roles (1, 2). However, it is
the core SH3-GUK module and its adjacent unique domains
that often have a dominant role in the regulation of transmem-
brane ligand binding, protein cross-linking, and localization to
the appropriate subcellular domain.
The structural basis for the regulatory properties of the var-
ious MAGUKs is poorly understood. To date, the only core
motif that has been resolved at an atomic level belongs to
PSD-95 (postsynaptic density protein 95) (3, 4), a neuronal pro-
tein involved in the regulation of postsynaptic gated ion chan-
nel. The structure reveals that the SH3 and GUK domains are
not simply arranged like pearls on a string but rather are inter-
connected. The interdomain interaction is via a -strand that
originates after the GUK domain that returns to become an
additional strand of the SH3 -sheet. The protein binding
properties of the coremodule appear to be dependent upon this
interdomain interaction because mutations that disrupt this
structure also disrupt interactions of the GUK domain with its
ligands (5, 6). Thus, it may be more realistic to consider the
SH3-GUK region as a single interdependent structural module.
However, although the secondary sequences within the core
motifs of MAGUKs are fairly well conserved, there are enough
differences to question whether or not the overall structural
fold of the SH3-GUK core is conserved.
TheU5 region (unique region 5), which is located toward the
C terminus of the SH3 domain just prior to the fifth -strand,
plays an important functional role in MAGUKs. In some
MAGUKs, it is a protein-binding motif (7–9), whereas in oth-
ers, it is critical for localization to the appropriate subcellular
domain (2, 10, 11). In hDlg/SAP97, this region has multiple
alternative splices, and this splicing contributes to diversity in
protein ligand binding affinity and function (10). The varied
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role for this motif is consistent with its sequence being highly
diverged between the different MAGUKs. Interestingly,
although the U5 region in PSD-95 is rather small compared
with other MAGUKs, the structure of this motif was not com-
pletely resolved in the crystal structure, suggesting some struc-
tural flexibility in the absence of binding partners (3). Thus, in
one sense theU5motif can be thought of as an effector loop that
mediates domain-specific functions for a particular MAGUK.
However, the functional and biochemical diversity of the U5
region might also affect the packing and relative orientation of
the SH3 and GUK domains.
Tight junctions (TJ) are sites of cell-cell adhesion in epithelial
and endothelial cells that form a barrier that regulates the
movement of ions, solutes, and immune cells between cells. The
actual physical barrier is assembled from at least three families
of transmembrane proteins, including the claudins, occludin/
tricellulin, and junction adhesion molecules, which assemble
into highly organized strands in the plasma membrane (12).
The assembly of these transmembrane proteins into strands
and the formation of the barrier is dependent on the zonula
occludens (ZO) family of MAGUKs; ZO-1, ZO-2, and ZO-3
(Fig. 1A) (13). ZO MAGUKs contain the typical PDZ-SH3-
GUK core motif, which is preceded by two additional PDZ
domains, but are distinguished by unique C-terminal domains
of various lengths (reviewed in Ref. 14). The C-terminal
domains mediate interactions with the cortical actin cytoskel-
eton, whereas the N-terminal MAGUK domains bind to the
transmembrane components of tight junction strands and
other scaffolding or signalingmolecules that regulate TJ assem-
bly. The three ZO MAGUKs clearly share some functional
roles, and recent genetic studies indicate that there is a certain
amount of functional redundancy between ZO-1 and ZO-2
within the TJ (13, 15, 16). Either ZO-1 or ZO-2 appears to be
sufficient for formation of a functional barrier in cultured cells,
but the deletion of both ZO-1 and ZO-2 in epithelial cells dis-
rupts the TJ barrier and prevents the assembly of TJ transmem-
brane proteins described above into strands (13). Thus, ZO
MAGUKs are a critical scaffold for TJ assembly.
The SH3-GUK module is a critical element of tight junction
assembly. Recent studies in cells deficient for ZO MAGUKs
indicate that the SH3-GUKmodule is necessary for rescue of TJ
strand assembly and the formation of the barrier (13, 17). This
is perhaps not surprising because the SH3 and GUK domains
bind to several structural and signaling components of tight
junctions (14), and the U5 motif that links these domains is
required for localization of ZOMAGUKs to the TJ (2). In addi-
tion, we have recently demonstrated that regulated binding to
the core module is equally critical. We have found that the U6
region, which is immediately distal to the GUK domain, can
regulate occludin binding to the GUK domain in vitro and U5
localization to the TJ in vivo (2). Finally, deletion of the U6
region results in the ectopically located formation of TJ strands
throughout the cell. Thus, the U6 region forms a second “effec-
tor loop,” which regulates the function of the core module. A
clue as to how this regulation may function is provided by the
discovery presented here that the U6 region binds to the SH3-
GUK (SG) module in a divalent metal-dependent manner and
competes with calmodulin for binding to the GUK domain.
To better understand how the SH3-GUK module and its
associated effector domains regulate the temporal and spatial
assembly of tight junctions, we have solved the crystal structure
of the ZO-1 SH3-GUK region to 2.6 Å resolution. The ZO-1
SH3-GUK module has similarities to the homologous module
of PSD-95 but also shows several significant differences. Most
noticeable is the different interdomain angle, with ZO-1 being
more open.A general conclusion concerningMAGUKproteins
is that the -strand following the GUK domain is a component
of the SH3 domain. At the same time, the angle between the
SH3 and GUK domains is variable among the different
MAGUKproteins. Comparison of the ZO-1 SH3-GUKmodule
structure with that of PSD-95 and ZO-3 has allowed us to iden-
tify the region within the GUK domain that forms the hinge
region between the domains. Furthermore, analysis of the elec-
trostatic surface potential of ZO-1 reveals a highly basic face to
the ZO-1molecule. Binding studies indicate that this basic sur-
face acts to bind calmodulin and the U6 region. Of note, the
binding site for calmodulin and U6 has been revealed to be
located at theGUKdomain, on the same face as theU5 region of
the SH3 domain, and both are at opposite ends from the hinge.
Furthermore, we present data revealing that the U6 region
binds to the SGmodule in a divalent metal-dependent manner.
We propose that yet-to-be-identified ligands of the U5 region
and GUK domain are regulated by the binding of calmodulin
and/or the U6 region and that these interactions control TJ
assembly.
EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification of ZO-1 Fragments—
For details on the cloning, expression, and purification of the
ZO-1 constructs described here, see the supplementalmaterial.
Crystallization, Data Collection, and Processing—The
T709C SGU5 (native and selenomethionine) protein crystal-
lized at room temperature by the hanging drop vapor diffusion
method in 0.1 M HEPES, pH 7.5, 7% isopropyl alcohol, 15–20%
polyethylene glycol 3350 (w/v), and 1–5 mM dithiothreitol. A
protein/reservoir volume ratio of 2:1 was used, and the drop
was equilibrated against 750 l of reservoir solution. Crystals
appearedwithin aweek and grewup to300 80 80m.To
obtain higher resolution diffraction, the crystals were dehy-
drated by serial transfer to a solution of increasing polyethylene
glycol 3350 concentration of up to 45%. The final dehydration
solution also acted as the cryoprotectant, and the crystals were
flash-frozen in liquid nitrogen. De novo phasing was achieved
by soaking the crystals in various mercury-containing com-
pounds at 1mM concentration. X-ray data were collected at the
SERCAT beamlines at the Advanced Photon Source and pro-
cessed with XDS (18).
Structure Determination and Refinement—Although dehy-
dration of the crystals usually resulted in cell shrinkage, the
heavy atom soaks elongated the unit cell despite back-soaks
into the dehydration/cryoprotectant solution (supplemental
Table 1). The selenomethionine crystals were especially radia-
tion-sensitive; thus, data sets at the peak and edge wavelengths
were collected on separate crystals. Only the combination of
several data sets from multiple derivatized crystals using mul-
tiple isomorphous replacement with anomalous scattering
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resulted in the program SOLVE (19) finding heavy atom sites
with relevant occupancy and a reasonable figure of merit of
0.43. These phases were extended and modified using
RESOLVE (20). The electron density maps calculated using the
improved phases allowed us to trace both the SH3 and GUK
domains. Iterative refinement and model building using O (21)
yielded the final model that spans residues 516–588 and 626–
803 (residues 589–625 aremissing from the SGU5 construct)
with loop residues 684–686 lacking unambiguous electron
density. TLS refinement was applied during the final stages of
refinement using two groups, one comprising the SH3 domain
from 516 to 641 and the other of the GUK domain from 642 to
803. The stereochemical properties of the final model (Protein
Data Bank code 3LH5) were analyzed using PROCHECK. For
data collection and refinement statistics, see supplemental
Table 1. To compare the overall
structure and domain orientations
of SGU5 relative to those of
SG, molecular replacement using
PHASER was performed using the
SH3 and GUK domains of SGU5
as separate search models on a
3.7 Å native SG data set. Rigid
body refinement with the SH3 and
GUK as independent domains was
performed on the molecular replace-
ment solution followed by restrained
refinement. Figures were made with
PyMOL.
Pull-down Assays—The binding
assays were done as previously
described with minor modifications
(22). Prior to performing the bind-
ing experiment, the SG and mutant
proteins were dialyzed against 50
mM Tris-HCl, pH 7.5, 100 mM
sodium citrate, pH 7.5, 100 mM
NaCl, and 1mMdithiothreitol. A 1:3
ratio (10 M, 30 M) of GST-CaM/
GST-U6 to SG/mutant was used.
GST-CaM/GST-U6 was first im-
mobilized onto glutathione-Sepha-
rose beads (GE Healthcare) and
washed with a binding buffer of 50
mMTris-HCl, pH 7.5, 100mMNaCl,
1 mM dithiothreitol, and 1 mM
CaCl2. SG/mutant protein was then
added, incubated for 30min at room
temperature, and washed with
binding buffer to remove unbound
ZO-1. To test themetal dependence
of U6 binding to ZO-1, SG/SGU5
was added to immobilized GST-U6
previously equilibrated with 50 mM
Tris-HCl, pH 7.5, 100 mM NaCl, 1
mM dithiothreitol, and either 1 mM
MgCl2 or CaCl2 or 20 mM EDTA.
After incubation, the samples were
washed with their respective binding buffers and analyzed
using SDS-PAGE. Control samples of ZO-1 incubated with
GST aswell as with the glutathione-Sepharose beadswere done
in parallel with the experimental samples.
RESULTS AND DISCUSSION
Structure Determination of the ZO-1 SH3-GUK Module—
The initial crystals of the ZO-1 SG region diffracted poorly.We
surmised that flexibility in the U5 region is a causing crystal
disorder that limits the diffraction (for a schematic of ZO
domain organization, see Fig. 1A). This hypothesis was based
on the observation that the homologous region of theMAGUK
PSD-95 was only partially observed in the electron density (3,
4). A ZO-1 construct lacking the U5 region, referred to as
SGU5, crystallized in conditions comparable with those used
FIGURE 1. Domain organization of ZO proteins and the structure of the SH3-GUK domains of ZO-1.
A, domain organization of the ZO MAGUKs. The canonical MAGUK protein binding motifs (PDZ, SH3, and GUK)
are separated by “unique” (U) regions of high sequence diversity. TJ binding partners of ZO-1 are mapped
above their known interaction domain with the transmembrane strand components labeled in red (reviewed in
Ref. 14). Those interactions that are also conserved in ZO-2 and ZO-3 are indicated, and the section of ZO-1
whose structure is presented here is indicated by dashed square brackets. B, ribbon diagram of the ZO-1 SH3
(cyan) and GUK (green) domains. The fifth strand of the SH3 domain and the strand following the GUK domain
form the interdomain linkage (pink). The ZO-1 construct used for the structure determination lacked the U5
region; arrow 1 points to the truncation point (orange highlight). The entire structure could be traced with
confidence except for 3 residues located at the NMP-binding region at the GUK domain (arrow 2, orange
highlight).
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with SG and produced similar looking crystals. Diffraction data
on SGU5 crystals extended to 3.2 Å in the identical space
group and unit cell dimensions comparable with those of SG
crystals. We further improved the resolution limit to 2.6 Å by
the process of crystal dehydration. Molecular replacement
using the known PSD-95 structures of the SH3-GUK domains
failed. Thus, the structure was solved using experimentally
derived phases from selenomethionine-containing protein and
mercury-soaked cysteinemutant of SGU5 (see “Experimental
Procedures”). Data collection and refinement statistics are pre-
sented in supplemental Table 1.
The Intramolecular Interaction between SH3 and GUK Do-
mains Is Conserved in ZO-1—A ribbon diagram of the ZO-1
SH3-GUK region is shown in Fig. 1B. As in PSD-95, we observe
that the SH3 and GUK domains form an interdependent struc-
tural unit. The SH3 domain (cyan) is linked to theGUKdomain
(green) by two anti-parallel strands (pink). The first strand of
this interdomain linkage is the fifth strand of the SH3, whereas
the second strand is an extension from the C terminus of the
GUK domain that returns to contribute to the -sheet in the
SH3 domain. In fact, this strand that follows the GUK sequence
can be viewed as an integral part of the ZO-1 SH3 domain, and
it has been labeled strand 6 in Fig. 1B to highlight this role (in
contrast, strands in the GUK domain are indicated by letters in
Fig. 2). Thus, as observed in the structure of PSD-95 SH3-GUK,
the SH3 domain builds a six-stranded -sheet, which is differ-
ent from the canonical five-stranded SH3 domain of Src itself
(for a discussion, seeMcGee et al. (3)). Apart from this interdo-
main linkage, the SH3 and GUK domains of ZO-1 lack any
structurally significant interactions.
The U5 region, absent in our structure, would connect the
sole helix of the SH3domain and the loop that precedes the fifth
-strand. The location of the 36-residue U5 deletion is high-
lighted in orange and indicated by arrow 1 in Fig. 1B. The length
and sequence homology of U5 is quite variable among
MAGUKs, suggesting that it might be a structurally and func-
tionally distinct binding region in the different proteins. The
observation that the U5 domain was not seen in two earlier
PSD-95 crystal structures of the SH3-GUK region despite being
a part of the construct and the fact that in the recent structure of
the ZO-3 SH3-GUK domain the U5 could also not be traced
(see below) suggest intrinsic high flexibility for the U5 in the
absence of a binding partner. It is unlikely that removal of
the U5 from ZO-1 had a significant effect on the overall struc-
ture reported here because both SG and SGU5 crystallized
in the same space groupwith similar unit cells. This implies that
the truncation of U5 did not change the conformation of SG
and was confirmed later by our analysis of the 3.7 Å SG data set
(see below).
We could trace the entire SH3-GUKmodule except for three
residues in a loop in the GUK domain that were unresolved.
The approximate location of the missing three residues is
shown in orange and designated by arrow 2 in Fig. 1B. This loop
is much shorter in ZO-1 than in PSD-95 (see sequence align-
ment in Fig. 2). Interestingly, this region is close to and on the
same face as the U5 region. Like U5, this loop is highly variable
FIGURE 2. Sequence alignment of SH3-GUK modules from human ZO proteins and rat PSD-95. The initial alignment was accomplished using ClustalW and
later improved manually. Residues conserved in all four sequences are highlighted in black, and those present in three sequences are highlighted in gray. The
secondary structure elements shown above the sequences are based on ZO-1 and maintain the color-coding of Fig. 1B. The boundaries for the residues deleted
from the SGU5 construct used for the structure determination are indicated. *, the cis-proline residue in PSD-95 (Pro714) that is responsible for the acute angle
between its SH3 and GUK domains. Residues in ZO-1 helix V that were mutated are indicated in orange letters for the triple mutant, with the two additional
residues for the pentamutant shown in red.
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in length and sequence homology among MAGUKs. It is pos-
sible that the presence of the U5 region would stabilize this
GUK loop. Alternatively, this loop may become more ordered
upon binding of a protein-ligand to the U5 region.
The SH3-GUK Regions of ZO-1 Adopt a More Open Confor-
mation than PSD-95—Sequence alignment of the SH3-GUK
regions of human ZO-1 and rat PSD-95 reveal a low 25% iden-
tity/40% similarity (Fig. 2), and
superposition of ZO-1 and PSD-95
SH3-GUKregions revealsmajor dif-
ferences in the relative position of
the two domains. When the SH3
domain is used as the base for the
alignment (Fig. 3A), it is immedi-
ately apparent that the domains in
PSD-95 adopt a considerably more
closed conformation than that
adopted by the domains in ZO-1.
To understand this difference in
domain packing, we analyzed the
interactions between the SH3 and
GUKdomains in the twoMAGUKs.
Surprisingly, even in the more com-
pact domain arrangement in PSD-
95, there are very few interdomain
interactions other than those that
involve the terminal -strand com-
plementing the SH3 -sheet (colo-
red pink for ZO-1 and red for
PSD-95). The sole additional inter-
domain interaction in PSD-95
occurs between the side chain of
Arg434 and the main chain car-
bonyl group of Phe688. Because
both of these residues are also
present but do not interact in the
open conformation in ZO-1, the
more closed interdomain confor-
mation in PSD-95 cannot be ac-
counted for by this interaction.
Why then do the domains in
PSD-95 adopt a more closed ar-
rangement relative to the domain
arrangement in ZO-1? The compar-
ison of our ZO-1 structure with that
of PSD-95 allowed us to identify the
residues that act as hinges between
the SH3 and GUK domains. The
SH3 and GUK domains are con-
nected via two hinges, which are
formed by loop residues placed
between secondary structure ele-
ments. Hinge 1 is located between
strand 5 of the SH3 domain and
strand A of the GUK domain, and
Hinge 2 is located between helix VI
of the GUK domain and strand 6
(Fig. 2). The reason for the acute
angle between the SH3 and GUK domains of PSD-95 seems to
lie in the presence of a cis-proline (Pro714) at Hinge 2 (Fig. 3A,
inset). In contrast, ZO-1 has a glutamine residue at the equiva-
lent position, allowing for an obtuse angle between the
domains. Thus, the more compact arrangement of the PSD-95
SH3-GUK region relative to that in ZO-1 is not due to unique
interdomain interactions that stabilize the closed state. Rather,
FIGURE 3. ZO-1 adopts a more open interdomain conformation relative to PSD-95. A, overlay of the SH3-
GUK modules of ZO-1 (cyan and green) and PSD-95 (purple and magenta). The superposition was generated by
aligning residues of the SH3 domains. The two strands forming the interdomain linkage are colored pink for
ZO-1 and red for PSD-95. When the SH3 domains are aligned, the GUK domains occupy significantly different
positions, with the PSD-95 adopting a more closed state. This difference in interdomain angle is attributed to
the nature of the residue located between the terminal GUK helix VI (labeled with an asterisk) and -strand 6. In
PSD-95, a cis-proline (Pro714) forces an acute angle between these secondary structure elements (see inset).
ZO-1 has a glutamine residue at this position, allowing for a more open conformation. B, superposition of the
SH3 domains. The deleted U5 region (orange trace) in ZO-1 is indicated by an arrow. In PSD-95, despite the
presence of the U5 residues, only a section could be traced, with two arrows indicating the break. Note that
the sole helix located within the SH3 domain adopts a different angle in ZO-1 and PSD-95 (double-headed gray
arrow) relative to the core of the SH3 domain. C, superposition of the GUK domains. PSD-95 has a significantly
longer insert at a region called the NMP-binding domain (see Fig. 2), with ZO-1 having only a short loop (the
three residues that could not be modeled in this loop are shown in orange). When using the GUK residues for
calculating the superposition, the interdomain strands (pink and red for ZO-1 and PSD-95, respectively) do not
overlay well (indicated by two arrows). The converse is true when calculating the overlay with SH3 residues (B).
Thus, the interdomain strands are an integral part of the SH3 domain.
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this closed state is a result of a hinge region that is limited in the
angle it can support between the domains. The analogous hinge
region in ZO-1 does not contain the constraining proline resi-
due and can therefore adopt a more open state.
Comparison of the SH3 Domains and Different Angles between
theHelical Stem of theU5Region and the SH3-Sheet—Although
the aggregate SH3-GUK region of ZO-1 overlays poorly on the
homologous region from PSD-95, the individual domains over-
lay much better. The strands of the SH3 domain overlay nearly
perfectly, including strand 6, which originated after the end of
the GUK domain (Fig. 3B). In our structure of SGU5, the
missing U5 domain would be located between helix a and
strand 5 (Fig. 1B). PSD-95 has amuch shorter U5 region, and in
its crystal structure, not all of it could be traced. Interestingly,
the angle between strand 4 and helix a of the SH3 domain is
significantly different between PSD-95 and ZO-1 (Fig. 3B, gray
double-headed arrow). The recently deposited structure of
ZO-3, which was solved using a construct that contained the
intact U5 region, has a strand-to-helix angle identical to that in
our U5-deleted structure of ZO-1. This demonstrates conclu-
sively that this difference in angles (between the SH3 -sheet
and the helix that acts as a stemof theU5 region) betweenZO-1
and PSD-95 is not due to the use of the U5 construct but
rather to an intrinsic property of ZO proteins. Thus, the helix
stem of the U5 region in ZO-1 presents the ligand-binding res-
idues of U5 at a different angle to potential binding partners in
comparison with PSD-95. This difference suggests the possibil-
ity that upon binding of ligands to U5, the helix responds by
changing its relative angle to the SH3 -sheet.
Comparison of the GUK Domains, ZO-1 Lacks the NMP-
binding Region—The name for the GUK domain originates
from sequence similarity to guanylate kinase, an enzyme that
catalyzes the conversion of GMP toGDP. Of note, no apprecia-
ble guanylate kinase activity has been measured for any
MAGUK protein (23, 24), and even the question of whether
nucleotides bind toMAGUKshas been controversial.McGee et
al. (3) could not detect binding of GMP to PSD-95 using equi-
librium dialysis experiments. In contrast, Tavares et al. (4)
observed GMP in their structure of the PSD-95 SH3-GUK
region, but that could have been due to stabilization supplied by
a guanidine molecule that was present in the crystallization
solutions. Nevertheless, based on homology to the enzyme gua-
nylate kinase and the fact that 10 of 11 residues involved in the
binding ofGMPare also present in PSD-95, a region of theGUK
domain was named as the NMP-binding region (Fig. 2).
However, it is notable that the so-calledNMP-binding region
is totally missing in ZO-1. Instead, a short flexible loop of 14
residues (compared with 46 residues in PSD-95) substitutes
for this domain. This is the one loop in theGUKdomain thatwe
could not build in its entirety (the three missing loop residues
are highlighted in orange in Fig. 3C). Since this loop is on the
same face as the U5 region that originates from the SH3
domain, it is possible that upon ligand binding to theU5 region,
this loop becomes stabilized.
The Interdomain Strands FormaRigid Link between SH3 and
GUK—The overlay of the GUK domains presented in Fig. 3C
was carried out by aligning only residues that belong to the
GUK domain. Also shown are the residues that build the inter-
domain linkage of anti-parallel -strands (pink for ZO-1, red
for PSD-95). Although the GUK domains align well between
the MAGUKs, the interdomain strands do not (arrows in Fig.
3C). In contrast, the analogous superposition using the SH3
residues results in a good fit for the core SH3 and for the inter-
domain strands (Fig. 3B). This fixed orientation relative to the
SH3 arises from a strictly conserved tryptophan residue
(Trp799) located in strand-6 that orients its side chain deep into
a hydrophobic depression in the SH3 domain (supplemental
Fig. S1). This side chain buttresses the interdomain interaction
made via the main chain atoms of strands 5 and 6. Thus, the
interdomain strands behave as a rigid body that belongs to the
SH3 domain and not to the GUK domain. The hinges between
the domains are at the GUK end of these two strands.
Electrostatic Analysis of the ZO-1 SH3-GUK Region and
Implications for Ligand Binding—The function of the different
modules inMAGUKs is to bind various protein ligands in order
to assemble multiprotein complexes. Regulation of these inter-
actions has significant implications for complex assembly and
function (2, 10, 25, 26). In the case of ZO-1, we have shown that
the GUK domain is sufficient to bind calmodulin and that this
interaction is calcium-dependent (22). No canonical calmodu-
lin-binding sequences were identified in the GUK domain, sug-
gesting a novel mode of interaction. Calmodulin is a highly
acidic protein. Therefore, we examined the surface charge dis-
tribution of SH3-GUK, making the prediction that a basic sur-
face would facilitate the interaction with calmodulin. The GUK
domain of ZO-1 is indeed highly basic with 13 arginine and 12
lysine residues (pI of 10). The electrostatic surface potential of
ZO-1 SH3-GUK in two orthogonal views is presented in Fig. 4.
Most pronounced is the concentration of positive charges in
and around the vicinity of helix V of the GUK domain (Fig. 2).
To test if the basic residues in this helix participate in binding to
calmodulin, we generated charge elimination and charge rever-
sal mutations and used a pull-down assay to measure binding.
The charge eliminationmutants had alanine residues substitut-
ing for Lys749, Arg752, and Lys753 (for the location of these res-
idues in the sequence see Fig. 2; for location in the structure, see
Fig. 4C). Pull-down assays showed that SG binding to calmod-
ulin was only mildly weaker to this SG variant (Fig. 5A, labeled
TM(A)). Similarly weakened binding was observed with a vari-
ant in which these basic residues were substituted with oppo-
sitely charged carboxylic acid residues (K749D/R752D/K753E;
Fig. 5A, TM(D/E)). Mutating additional two basic residues in
this helix (K760E/K763E) further weakened the interaction
between the SH3-GUK module and calmodulin (Fig. 5A,
PM(D/E)). We recognize that the decrease in the intensity of
the pull-down band of the SG mutants versus that of the wild
type is moderate (range 15–40%, depending on the mutant
tested). However, this effect is significant because it was reca-
pitulated in three independent experiments (supplemental
Table 2). These pull-down results suggest that the positively
charged surface centered about helix V of the GUK domain is a
component of the calmodulin binding site but that other ele-
ments of SG participate in calmodulin binding. Experiments
are under way to identify more precisely the residues that are
essential for calmodulin binding.
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Similar to calmodulin, the U6 region of ZO-1 contains a high
density of carboxylic acid residues. Although U6 affects the
function of the GUK domain in vivo (2), there are no data
addressing whether it does this by binding the GUK domain.
Thus, we asked whether the U6 region might bind to the GUK
domain and whether the interaction requires helix V. Using a
GST-linkedU6 construct, we discovered that theU6 region can
pull down the SG construct in cis (Fig. 5B). This result was
recapitulated using the SGU5 construct (Fig. 5C), indicating
that the interaction between U6 and SG is independent of the
U5 region. Intriguingly, the interaction betweenU6 and SGwas
revealed to be divalent cation-dependent. With magnesium,
the interaction between U6 and SG or SGU5 was weaker, as
indicated by about 50% pull-down efficiency. In contrast, cal-
ciumpromoted a complete 1:1 pull-down.The absence ofmetal
achieved by adding the chelator EDTA abolished binding.
What could be the possible role of the divalent metal in pro-
moting the interaction between SG and U6? One option is that
the metal acts as a bridge linking carboxylic residues of the two
domains. Alternatively, the metal can be acting to stabilize a
binding-compatible structure of U6. Using the charge elimina-
tion and charge reversalmutants of the SGhelix V, we observed
that the basic residues of the helix are required for the interac-
tion with the U6 region (Fig. 5D). The triple charge elimination
mutant resulted in diminished binding, whereas both charge
reversal mutants totally abrogated binding. The implications of
these results are 2-fold. First, helix V of the GUK domain is
identified as a necessary component of the U6 binding surface;
second, the results are consistent with the divalent metal play-
ing a structural role in the SG-U6
interaction by stabilizing the struc-
ture of theU6 region (in the alterna-
tive scenario, it is acidic residues
that are important for binding, not
basic residues).
Because both the U6 region and
calmodulin interact with helix V of
the GUK domain, we asked whether
this binding is mutually exclusive.
To address this, we tested the ability
of calmodulin to bind to a construct
that has the SH3, GUK, and U6
within the same polypeptide (called
SGU6). In our pull-down assay,
SGU6 failed to bind to calmodulin
(Fig. 5E). Our interpretation of this
observation is that the U6 region
can act to regulate the ability of cal-
modulin to bind to ZO-1.
These structure-guided ligand-
binding studies between the ZO-1
SG module and calmodulin or the
U6 region have identified the basic
surface on the GUK domain as
important for the interaction. Inter-
estingly, both the interaction with
calmodulin and that with the U6
region is dependent on the presence
of a divalent metal. Also, in both cases, the metal seems to play
a structural role that converts either calmodulin or the U6
region into a conformation that is compatible with binding to
the GUK domain. However, this interaction with the GUK
domain is mutually exclusive between calmodulin and the U6
region (Fig. 5E). Last, the studies with the U5-truncated con-
struct of SG show that these interactions are independent of U5
region (Fig. 5, C and E). This is noteworthy because the U5
region would be on the same face of the molecule as the impor-
tant helix V of the GUK domain. To date, no proteins that bind
solely to the U5 region have been identified. However, the U5
region is required for localization of ZO-1 in vivo, and we have
previously demonstrated that the U6 domain can inhibit the
localization of GFP-tagged SG to the tight junction. Thus, we
propose that calmodulin or U6 binding to the SG domain may
act to regulate the binding of ligands to the U5 region.
The SH3-GUK Region of ZO-3 Has a More Open Conforma-
tion than ZO-1—As we were preparing this paper, the Struc-
tural Genomic Consortia deposited the structure of the ZO-3
SH3-GUK region (Protein Data Bank code 3KFV), allowing us
to contrast it with our ZO-1 structure. On the level of primary
sequence, human ZO-1 and ZO-3 are 51% identical/70% simi-
lar (see Figs. 2 and 6, A and B). Interestingly, when the SH3-
GUK domains of ZO-1 (cyan and green) and ZO-3 (gold) were
overlaid based on superpositioning the SH3 domains, we found
that the relative conformation of the SH3 and GUK domains in
the ZO-3 structure is even more open than what we observe
with ZO-1 (Fig. 6C). The basis for the difference in relative
orientation is best illustrated by comparing the orientation of
FIGURE 4. The GUK domain of ZO-1 is characterized by a positively charged surface. A, a ribbon diagram of
ZO-1 with all GUK domain lysine and arginine residues shown. B, electrostatic surface potential at the same
orientation as in A. C, view rotated 90° relative to A. D, electrostatic surface potential at the same orientation as
in C. A congregation of basic residues occurs at and near helix V of the GUK domain. In C, the basic residues
probed by mutagenesis are colored dark blue, and all others are shown in light blue.
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the interdomain strands relative to
each domain. For example, when
the GUK domains of ZO-1 and
ZO-3 are overlaid, the interdomain
strands are poorly aligned (Fig. 6D,
arrow 2). In contrast, these interdo-
main strands align perfectly with
the rest of the SH3 domain (Fig. 6E)
when the superposition is calcu-
lated using only residues from the
SH3 domain. This recapitulates the
previous analysis comparing ZO-1
to PSD-95 and solidifies our conclu-
sion that the hinge region that con-
nects the SH3 to the GUK domain is
located between the interdomain
strands and the GUK domain (and
not, as previously predicted, within
U5).
Although the interdomain con-
formations are significantly differ-
ent between ZO-1 and ZO-3, the
individual domains alignwell, with a
root mean square deviation of 0.95
Å (over 147 atoms) and 0.73 Å (over
73 atoms) for the GUK and SH3
domains, respectively (Fig. 6, D and
E). Themost pronounced difference
in the GUK domains of these pro-
teins is that we could model a larger
part of the “NMP-binding loop” in
ZO-1 (Fig. 6D, arrow 1). The most
significant difference between the
SH3 domains of ZO-1 and ZO-3 is
in the conformation of the residues
flanking the U5 region. It is notable
that although the U5 region was
present in the ZO-3 construct, the
majority of this domain was not
modeled (absent from the ZO-3
model are residues Val572–Arg606).
This is consistent with our predic-
tion that absent a ligand, the U5
region remains flexible. It is also
notable that in the ZO-3 structure,
the helix preceding the U5 region is
one turn longer than the homolo-
gous helix in our U5-deleted ZO-1
structure (Fig. 6E, arrow 1). More-
over, the region following U5 in
ZO-3 is a helix in that is replaced by
a loop in ZO-1 (Fig. 6E, arrow 2).
The presence of this additional helix
after the U5 region and the more
open interdomain confirmation are
likely to be linked because the helix
precludes the more closed state we
observe in ZO-1. The question
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remains, are these inherent differences between ZO-1 and
ZO-3, or are the differences a result of the U5-truncation in our
construct of ZO-1? To address this issue, we took advantage of
the x-ray data set that we collected from a crystal of the intact
ZO-1 SH3-GUK region (albeit to 3.7 Å resolution). We per-
formed molecular replacement using the model we have built
based on the SGU5 data. Importantly, we performed this cal-
culation using two independent models, one for the SH3
domain and one for the GUK domain. By doing so, we allow
unbiased placement of each domain relative to the other. If the
act of truncating the U5 region caused the more closed state,
then the structure from the crystal with the U5 would display
the more open conformation, as observed with ZO-3. The
result is shown in Fig. 7. The domains of the intact region (SG)
overlay nearly perfectly on the domains of the truncated protein
(SGU5).
The above analysis suggests that the different conformation
we observe between ZO-1 and ZO-3 is a true difference that is
not due to the truncation of U5 in our ZO-1 construct. Consis-
tent with this interpretation, examination of the primary
sequences reveals that the U5 region of ZO-3 is in fact eight
residues longer than that of ZO-1, suggesting that theU5 region
confers different functions in the two proteins (Fig. 2). What is
the functional relevance of this difference? In ZO-1 the U5
region is required for localization to the tight junction (2). A
previous study (13) has shown that ZO-3, although it contains a
U5 region, cannot localize to the tight junctions in the absence
of either ZO-1 or ZO-2. Thus, we propose that the variation in
conformation between ZO-1 and ZO-3 (i.e. ZO-3 being more
open), which is directly correlated to the difference in the
length of the U5 region, is the reason that ZO-3 lacks this local-
izing function.
Conclusions—Comparing and contrasting the structure of
the ZO-1 SH3-GUK module with that of PSD-95 and ZO-3, in
combination with our ligand binding studies, provide us with
an important insight into the general characteristics of
MAGUK proteins and of ZO-1 specifically. We reveal that
although the interdependent folding of the SH3 and GUK
domains is conserved in at least three MAGUKs, the angle
between the SH3 and GUK domains is variable, and the hinge
point between these domains is at the interface between the
GUK domain and strands 5 and 6 of the SH3 domain. The U5
region, which is variable in length and sequence among
MAGUKs, should be considered a variable surface loop on the
SH3 domain rather than a sequence connecting SH3 and GUK.
Additionally, this region is quite flexible in all MAGUKs in the
absence of a ligand.
The role of the U5 effector loop in ZO-1 is poorly under-
stood. There are currently nowell established binding partners,
as there are for the U5 in several other MAGUKs (7–9). Nor is
there any evidence that theU5 region of ZO-1 regulates binding
to the SH3-GUK, as described for SAP97 (25). However, as in
several other MAGUKS (10, 11), the U5 effector loop is
required for localization of ZO-1 to the tight junction in vivo
(2). This observation indicates that theU5 domain of ZO-1, like
otherMAGUKs, is an important functional domain of theZO-1
core complex. Additionally, the difference in length of the U5
region between ZO-3 and ZO-1/ZO-2, which results in the
SH3-GUKmodule adopting a different interdomain angle, may
explain the inability of ZO-3 to localize to tight junctions (13).
The U6 region is also a critical regulator of ZO-1 function. In
vivo, it regulates the temporal and spatial organization of trans-
membrane proteins like occludin and claudins into functional
barrier strands (2). ZO-1 constructs lacking U6 form ectopic TJ
strands composed of the barrier-forming claudins, occludin,
and junction adhesion molecule proteins. How U6 regulates
strand assembly is unclear, but one suggestion from our data is
that U6 might regulate binding of various TJ ligands or regula-
tory proteins to the GUK domain. This hypothesis is supported
by our observations that a basic surface on the GUK domain
that includes helix V is all or part of the binding surface for
calmodulin and the U6 domain and that the U6 domain can
compete with calmodulin for binding to this helix. It is also
supported by our previously reported studies that demon-
strated that the U6 domain inhibits in vitro binding of occludin
to the SG (2). Together these observations allow us to speculate
that U6 inhibits occludin binding to GUK in vivo, preventing
ectopic strand formation. We speculate that there normally
FIGURE 5. Helix V of the GUK domain is important for binding to calmodulin and the U6 motif. A, GST-CaM was immobilized on glutathione beads and
incubated with various SG constructs in the presence of 1 mM CaCl2 and then washed to remove unbound protein. GST-CaM and bound proteins were resolved
by SDS-PAGE and stained with Coomassie Brilliant Blue. Lane 1, molecular weight markers; lanes 2, 5, 9, and 13, the fraction “bound” to GST-CaM after incubation
with SG, the triple charge elimination mutant (TM(A)), the triple charge reversal mutant (TM(D/E)), or the penta-charge reversal mutant (PM(D/E)), respectively.
Calmodulin binding to PM(D/E) and, to a lesser extent TM(D/E), is attenuated relative to SG. Lanes 3, 6, 10, and 14, supernatant (unbound fraction) after spinning
down the beads. Lanes 4, 8, and 12, controls, in which the proteins were simply incubated with the glutathione beads. The lack of a band shows that there is no
interaction between the SG constructs and the beads. Lanes 7, 11, and 15, controls in which GST alone on beads (instead of GST-CaM) was incubated with the
SG constructs. This shows that the SG constructs do not interact with GST. The ratio of SG or SG mutants relative to GST-CaM, calculated from the intensity of
the bands within the red box, is presented for each condition above the box. B, the U6 region binds SG in cis. Lanes 4, 8, and 12, proteins bound to GST-U6 after
incubation with SG in the presence of 1 mM MgCl2, 1 mM CaCl2, or EDTA, respectively. The binding of U6 to SG is dependent on divalent metal. Lane 1, molecular
weight markers. Lane 2, GST-U6 by itself on the beads. Lanes 3, 7, and 11, controls where the SG was incubated with glutathione beads, showing no nonspecific
interactions. Lanes 5, 9, and 13, supernatant (unbound) fraction after the pull-down. About 50% of GST-U6 binds SG in the presence of magnesium and 100%
in calcium, but little or none binds in the EDTA-containing condition. Lanes 6, 10, and 14, controls with GST instead of GST-U6. Quantified band ratios are shown
above the red box. C, experiment analogous to that in B but with SGU5 instead of SG. This demonstrates that the divalent cation-dependent binding of U6 to
SG is independent of the U5 region. D, experiment analogous to that in A but with GST-U6 instead of GST-CaM. We see that the charge reversal mutations (lanes
9 and 13) largely abolish the interaction between U6 and SG. The charge elimination mutations (lane 5) only moderately decrease the interaction. E, GST-CaM
was immobilized on glutathione beads and incubated with the ZO-1 construct SH3-GUK-U6 (SGU6), SH3-GUK (SG), or SH3-GUK that lacks U5 (SGU5). Lanes 1
and 15, marker lanes. Lane 2, GST-CaM bound to the beads. Lanes 3, 7, and 11, control conditions in which the protein, SGU6, SG, or SGU5, respectively, was
incubated with the glutathione beads; no nonspecific binding was observed. Lanes 4, 8, and 12, the fraction “bound” to GST-CaM after incubation with SGU6,
SG, or SGU5, respectively. GST-CaM does not pull down SGU6, but it does pull down SG and SGU5. Quantified band ratios are shown above the red box. This
demonstrates that the binding of calmodulin or the U6 region to the GUK domain of ZO-1 is mutually exclusive. Lanes 5, 9, and 13, supernatant (unbound
fraction) after spinning down the beads. Lanes 6, 10, and 14, controls in which GST alone on beads (instead of GST-CaM) was incubated with the SG constructs.
This shows that the SG constructs do not interact with GST.
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exists within the cell a temporal or
spatially regulated signal that dis-
places U6 and permits binding of
occludin only within the tight junc-
tion. However, we cannot yet rule
out the possibility that it is the
U6-regulated binding of alternative
GUK ligands that contributes to
strand assembly. Possible candi-
dates include calmodulin and the
actin-binding proteins Shroom and
cingulin (Fig. 1). Thus, we conclude
that the U6 region is also an impor-
tant effector loop, and how this loop
regulates strand assembly is cur-
rently under investigation.
We currently find it difficult
rationalize from the SH3-GUK
structure how occludin binds to the
GUKdomain. Peptide binding stud-
ies suggest that the occludin binding
site in SG includes a combination of
residues within U5 and GUK
domain helix IV and V (27). This is
not inconsistent with our structure
and would strongly support our
hypothesis that binding of the U6
region to helix V would regulate
occludin binding. However, our
previous structural and biochemical
studies (28), confirmed by our col-
leagues (29), indicate that the ZO-1-
binding domain in occludin is a pos-
itive charge face of a coiled-coil
domain (28). The addition of nega-
tively charged residues within this
region of occludin interfered with
ZO-1 binding (28). Thus, it is hard
to predict how occludin would bind
directly to this region of the GUK
domain, whose surface residues are
also overwhelmingly positive. We
can only hypothesize that some
modification, such as phosphoryla-
tion of SG, or some intermediary
protein may be critical for occludin
binding.
Finally, it seems very likely that
the activity of theU5 andU6 regions
is coordinated in vivo. Our structure
suggests that both of these effector
domains and the ligand binding
sites surrounding helix V of the
GUK domain are present on the
same surface of the SH3-GUKmod-
ule, distal from the flexible hinge
domain. This implies that any
change in the hinge angle would
FIGURE 6. Human ZO-1 adopts a different SH3-GUK interdomain conformation compared with ZO-3.
A, surface representation of ZO-1 in which the sequence conservation to ZO-3 is indicated by different colors:
green for identical residues, lime for similar residues, and orange for non-conserved residues. An arrow indicates
the location of the U5 region. B, an analogous representation rotated 180 degrees. C, superposition of ZO-1
(same color scheme as before) and ZO-3 (gold) based on aligning the SH3 domains. The SH3-GUK interdomain
angle is different, with ZO-3 adopting a more open conformation. The U5 region of ZO-3 could not be traced,
with the break indicated by two gold arrows. D, superposition of the GUK domains reveals a very similar fold.
The NMP-binding loop in ZO-3 could not be traced (arrow 1 points at the break), whereas we could model most
of this region in ZO-1 except the orange highlighted stretch. Because the proteins adopt a different interdomain
angle, the strands linking the domains do not align well (arrow 2). E, superposition of the SH3 domains shows
a nearly perfect overlay. This time the interdomain strands overlay well, indicating that they move as a rigid
body with the SH3 domain. Two arrows indicate the break in the U5 region of ZO-3 relative to the break in ZO-1
(orange trace). Note the extra helix in ZO-3 (arrow 2) relative to that of ZO-1.
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have a significant effect on the distance between the ligand
binding sites on the two surfaces. Interestingly, although theU5
is necessary for TJ localization in vivo, this localization is dis-
rupted by the U6motif, implying that there must be a trigger to
move U6 out of the way (2). This observation suggest that these
two effector loops functionally interact, and the SG structure
should allow further elaboration of how these effector loops
regulate TJ assembly in vivo.
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FIGURE 7. Presence of the U5 region in ZO-1 does not change the interdo-
main conformation. A 3.7 Å data set was collected on an SG construct con-
taining the U5 region (SG), and the structure was solved by molecular replace-
ment using the SH3 and GUK as two independent domains. This structure
maintains the interdomain positioning as observed in SGU5. The color
scheme of SG follows that of SGU5 but with a lighter shade.
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